Alteon, BioRap Technologies Ltd., Oxis deal

ALT and BioRap expanded a 2005 deal to give ALT rights to all BioRap’s cardiovascular diagnostic technologies. BioRap will receive an upfront payment and research funding

Read the full 261 word article

How to gain access

Continue reading with a
two-week free trial.